Sotac Pharmaceuticals Limited (NSE:SOTAC)
90.05
0.00 (0.00%)
Aug 20, 2026, 11:13 AM IST
Sotac Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 995 | 1,207 | 1,312 | 1,337 | - | - | |
Market Cap Growth | -27.96% | -8.00% | -1.86% | - | - | - |
Enterprise Value | 1,416 | 1,621 | 1,625 | 1,578 | - | - |
Last Close Price | 90.05 | 109.25 | 118.65 | 120.90 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 17.25 | 20.93 | 16.35 | 31.23 | - | - |
PS Ratio | 0.98 | 1.19 | 1.31 | 1.29 | - | - |
PB Ratio | 1.54 | 1.87 | 2.25 | 2.71 | - | - |
P/TBV Ratio | 1.81 | 2.20 | 2.56 | 3.09 | - | - |
P/FCF Ratio | 11.09 | 13.45 | - | - | - | - |
P/OCF Ratio | 5.90 | 7.16 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.39 | 1.60 | 1.62 | 1.52 | - | - |
EV/EBITDA Ratio | 7.77 | 8.89 | 9.58 | 17.90 | - | - |
EV/EBIT Ratio | 11.04 | 12.64 | 12.38 | 27.59 | - | - |
EV/FCF Ratio | 15.78 | 18.06 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.58 | 0.58 | 0.75 | 0.50 | 1.12 | 1.12 |
Debt / EBITDA Ratio | 2.06 | 2.06 | 2.58 | 2.82 | 2.90 | 0.93 |
Debt / FCF Ratio | 4.19 | 4.19 | - | - | - | 2.60 |
Net Debt / Equity Ratio | 0.56 | 0.56 | 0.71 | 0.43 | 0.61 | 1.11 |
Net Debt / EBITDA Ratio | 2.00 | 2.00 | 2.46 | 2.38 | 1.57 | 0.92 |
Net Debt / FCF Ratio | 4.06 | 4.06 | -1.95 | -0.62 | -13.94 | 2.59 |
Asset Turnover | 0.79 | 0.79 | 0.87 | 1.16 | 1.42 | 2.09 |
Inventory Turnover | 2.73 | 2.73 | 3.57 | 5.03 | 6.02 | 10.95 |
Quick Ratio | 0.59 | 0.59 | 0.70 | 0.69 | 0.55 | 0.45 |
Current Ratio | 1.33 | 1.33 | 1.36 | 1.39 | 1.03 | 0.94 |
Return on Equity (ROE) | 10.23% | 10.23% | 17.22% | 10.37% | 17.38% | 62.65% |
Return on Assets (ROA) | 6.22% | 6.22% | 7.14% | 4.00% | 6.10% | 12.24% |
Return on Invested Capital (ROIC) | 9.19% | 9.23% | 12.85% | 10.13% | 13.56% | 25.28% |
Return on Capital Employed (ROCE) | 17.10% | 17.10% | 18.00% | 9.30% | 19.10% | 89.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 5.80% | 4.78% | 6.12% | 3.20% | - | - |
FCF Yield | 9.02% | 7.43% | -16.27% | -25.33% | - | - |
Dividend Yield | 0.23% | 0.18% | 0.08% | - | - | - |
Payout Ratio | 1.92% | 1.92% | - | - | - | 15.98% |
Buyback Yield / Dilution | 0.02% | 0.02% | -0.67% | -36.35% | - | - |
Total Shareholder Return | 0.25% | 0.21% | -0.59% | -36.35% | - | - |